Open Orphan plc changed its name to hVIVO plc on 26 October 2022, learn more here.
Open Orphan plc has changed its name to hVIVO plc (Ticker: HVO)
Watch hVIVO’s Capital Markets Day 2022 presentation here.
At hVIVO, we understand the vital role we play in making infectious and respiratory disease products available to patients faster than otherwise possible, using human challenge trials. With origins dating back to 1947, hVIVO has a long history of scientific research and discovery which has helped to advance global health.
Our most valuable asset is our team, and we strive to promote a diversified and welcoming environment which allows our team to thrive. We are committed to ethical and compliant business practices, from the execution of our clinical trials to our interactions with our volunteers, clients, sponsors, vendors, and investors.
We understand our responsibility to reduce our impact on the environment whenever possible, we strive to minimise our carbon footprint through energy efficiencies, local and sustainable suppliers, and waste reduction.
We operate our trials in the highest quality safety, regulatory and ethical environment. We are committed to honesty, transparency and quality which is embedded in our Clinical Governance Policy and Business Code of Ethics.
Infectious diseases are a significant burden to global health, and hVIVO plays an important role in helping to bring vital vaccines & antivirals to the market faster than otherwise possible, using human clinical trials.
We place volunteers and patients at the heart of our business and carefully safeguard their wellbeing in clinical research and data protection, and ensure that their feedback is heard so that we can continually improve our processes.
Our employees are the key to our success; in line with our Diversity & Equal Opportunities Policy, we are focussed on building a strong corporate culture, with diversity and equality at the centre.
We understand our responsibility to reduce our impact on the environment; as part of our Environmental Policy, we are working towards implementing measurable metrics and targets to help minimise our carbon footprint.
Our Board of Directors is made up of a diverse range of professionals who are experts in their fields. A commitment to quality and integrity filters from the Board, company wide. We are committed to maintaining & improving our quality systems and policies to exceed the standards required.